These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 4947826

  • 1. Thyrocalcitonin: physiological importance and significance in renal failure.
    Munson PL.
    Am J Med Sci; 1971 Dec; 262(6):310-9. PubMed ID: 4947826
    [No Abstract] [Full Text] [Related]

  • 2. Recent advances in thyrocalcitonin research.
    Potts JT.
    Fed Proc; 1970 Dec; 29(3):1200-5. PubMed ID: 4910269
    [No Abstract] [Full Text] [Related]

  • 3. Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D.
    Mittleman R, Chausmer A, Bellavia J, Wallach S.
    Endocrinology; 1967 Sep; 81(3):599-604. PubMed ID: 4291806
    [No Abstract] [Full Text] [Related]

  • 4. [Calcitonin: nature, secretion mechanisms, therapeutic possibilities].
    Franchimont P, Heynen G, Reginster M, Denis F.
    Brux Med; 1973 Dec; 53(12):719-27. PubMed ID: 4360270
    [No Abstract] [Full Text] [Related]

  • 5. Detection of thyrocalcitonin in rat serum by direct tissue culture bio-assay.
    Au WY, Raisz LG.
    Endocrinology; 1970 Jun; 86(6):1231-8. PubMed ID: 5445765
    [No Abstract] [Full Text] [Related]

  • 6. Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
    Cundy T, Heynen G, Paton S, Ledingham JG, Russell RG, Oliver DO, Kanis JA.
    Proc Eur Dial Transplant Assoc; 1978 Jun; 15():524-31. PubMed ID: 740683
    [Abstract] [Full Text] [Related]

  • 7. Importance of endogenous thyrocalcitonin for protection against hypercalcemia in the rat.
    Cooper CW, Hirsch PF, Munson PL.
    Endocrinology; 1970 Feb; 86(2):406-15. PubMed ID: 5409935
    [No Abstract] [Full Text] [Related]

  • 8. [Recent findings on thyrocalcitonin and parathyroid hormone].
    Kohler H, Wernly M.
    Schweiz Med Wochenschr; 1969 May 17; 99(20):740-3. PubMed ID: 4891579
    [No Abstract] [Full Text] [Related]

  • 9. Calcium regulation in man.
    Copp DH.
    Mod Treat; 1970 May 17; 7(3):621-35. PubMed ID: 4920808
    [No Abstract] [Full Text] [Related]

  • 10. [Calcitonin].
    Orimo H.
    Nihon Ishikai Zasshi; 1971 May 17; 65(9):1125-41. PubMed ID: 4326158
    [No Abstract] [Full Text] [Related]

  • 11. An inhibitory effect of thyrocalcitonin on calcium release in vivo and on bone metabolism in vitro.
    Johnston CC, Deiss WP.
    Endocrinology; 1966 Jun 17; 78(6):1139-43. PubMed ID: 5920693
    [No Abstract] [Full Text] [Related]

  • 12. [Calcitonin--thyrocalcitonin, hormone of the ultimobranchial body].
    Perraro F.
    Folia Endocrinol; 1969 Apr 17; 22(2):119-65. PubMed ID: 4907630
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Kinetics of bone metabolism after thyrocalcitonin in man.
    Caniggia A, Gennari C.
    Calcif Tissue Res; 1968 Apr 17; ():Suppl:70. PubMed ID: 5721089
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical aspects of thyrocalcitonin.
    Gray TK, Ontjes DA.
    Clin Orthop Relat Res; 1975 Sep 17; (111):238-56. PubMed ID: 1098826
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.